Xprecia Prime Coagulation System
FDA 510(k) K230802 · Universal Biosensors Pty, Ltd.
510(k) numberK230802
Submission
- Device name
- Xprecia Prime Coagulation System
- Applicant
- Universal Biosensors Pty, Ltd.
Rowville, AU - Received
- March 23, 2023
- Decision date
- March 15, 2024
- Decision
- Substantially Equivalent (SESE)
- Type
- Dual Track 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- GJS – Test, Time, Prothrombin
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 864.7750
- Specialty
- Hematology
Other 510(k)s with product code GJS
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K253188 | CoaguChek XS Plus SystemGJS · Special | Roche Diagnostics | 10/24/2025SE |
| K251564 | microINR SystemGJS · Traditional | Iline Microsystems, S.L. | 07/21/2025SE |
| K243543 | microINR SystemGJS · Traditional | Iline Microsystems, S.L. | 02/27/2025SE |
| K220282 | i-STAT PTplus Cartridge with the i-STAT 1 SystemGJS · Traditional | Abbott Laboratories | 07/14/2023SE |
| K231711 | microINR SystemGJS · Special | Iline Microsystems, S.L. | 07/11/2023SE |
| K211485 | STA- NeoPTimalGJS · Traditional | Diagnostica Stago S.A.S | 12/23/2022SE |
| K212779 | Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-TestingGJS · Special | Coagusense, Inc. | 10/05/2022SE |
| K213426 | HemosIL ReadiPlasTinGJS · Traditional | Instrumentation Laboratory CO | 08/16/2022SE |
| K201185 | microINR SystemGJS · Traditional | Iline Microsystems, S.L. | 12/18/2020SE |
| K183255 | Coag-Sense Prothrombin Time (PT) / INR Monitoring DeviceGJS · Traditional | Coagusense, Inc. | 02/21/2019SE |
Questions and answers
When was Xprecia Prime Coagulation System cleared by the FDA?
Xprecia Prime Coagulation System (K230802) received a 510(k) decision of Substantially Equivalent on March 15, 2024, 358 days after the submission was received.
What is the product code of K230802?
The FDA product code is GJS – Test, Time, Prothrombin, a Class II (moderate risk) device regulated under 21 CFR 864.7750.